ESC 365 - Predicting the impact of low-density lipoprotein cholesterol lowering through different drug targets on risk of congenital heart disease

ESC Professional Premium Access

Predicting the impact of low-density lipoprotein cholesterol lowering through different drug targets on risk of congenital heart disease

Session: New findings in adult congenital heart disease

Topic: Pathophysiology and Mechanisms

Speaker: Doctor M. Ardissino (Cambridge, GB)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Maddalena Ardissino

Royal Papworth Hospital, Cambridge (United Kingdom of Great Britain & Northern Ireland)

3 presentations

0 follower

4 more presentations in this session

Risk stratification of non-cardiac surgeries in adult congenital heart disease

Speaker: Doctor A. Fischer (Muenster, DE)

Fractional flow reserve in anomalous aortic origin of coronary arteries to evaluate hemodynamic consequences of high risk anatomical features.

Speaker: Mr D. Verheijen (Leiden, NL)

Neo-aortic dimensions and coronary take-off angle in adolescent and young adult patients with transposition of the great arteries after the arterial switch operation

Speaker: Mr D. Verheijen (Leiden, NL)

Temporal trend in hospitalization among patients with congenital heart disease in Denmark: a nationwide study

Speaker: Doctor C. Lim (Copenhagen, DK)

Access the full session

New findings in adult congenital heart disease

Speakers: Doctor M. Ardissino, Doctor A. Fischer, Mr D. Verheijen, Mr D. Verheijen, Doctor C. Lim

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources